HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Vasodilator treatment of chronic heart failure: a chronic double-blind trial with prazosin and erythrityl tetranitrate].

Abstract
A chronic double-blind experiment was carried out with 32 patients with severe chronic stasis cardiac insufficiency, with concomitant idiopathic congestive cardiomyopathy and ischemic heart disease, in assessing the effect of vasodilators prazosin or erythrityl tetranitrate upon the decompensation symptomatics and hemodynamic indices. The clinical indices of cardiac insufficiency with hemodynamic signs of pre-loading, myocardial contractility and postloading of left ventricle were followed up. Besides vasodilators the patients were administered the ordinary maintenance therapy with digoxin and diuretics. The experiment was a double blind one, controlled by placebo-periods and covered a 6 months follow-up period. The combined venous-arteriolar vasodilator prazosin was reduced pre and post-loading, it increased the cardiac output, without essential changes in functional capacity of the patients with chronic cardiac insufficiency. Erythrityl tetranitrate, however, has no substantial effect on the clinical and hemodynamic indices of statis cardiac insufficiency even in higher doses. That suggests the necessity of the chronic cardiac insufficiency treatment to be carried out with vasodilators with venous and arteriolar effect.
AuthorsI Tomov, A Kaloianova, L Terzieva, A Elenkova, G Nikolov
JournalVutreshni bolesti (Vutr Boles) Vol. 20 Issue 6 Pg. 72-8 ( 1981) ISSN: 0506-2772 [Print] Bulgaria
Vernacular TitleLechenie na khronichnata sŭrdechna nedostatŭchnsot s vazodilatoatori--khronichen dvoĭno sliap opit s prazozin i eritritiltetranitrat.
PMID7039130 (Publication Type: Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Placebos
  • Quinazolines
  • Erythrityl Tetranitrate
  • Prazosin
Topics
  • Chronic Disease
  • Clinical Trials as Topic
  • Double-Blind Method
  • Erythrityl Tetranitrate (administration & dosage)
  • Female
  • Heart Failure (drug therapy, physiopathology)
  • Hemodynamics (drug effects)
  • Humans
  • Male
  • Placebos
  • Prazosin (administration & dosage)
  • Quinazolines (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: